18
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7305 | JQEZ5 | Histone Methyltransferase | |
JQEZ5 is an inhibitor of EZH2 lysine methyltransferase (IC50 = 11.1 nM). | |||
T13954 | UNC6852 | Histone Methyltransferase , Ligands for Target Protein for PROTAC | |
UNC6852 contains an EED ligand (IC50 = 247 nM) and a von Hippel-Lindau ligand and is a selective polycomb repressive complex 2 (PRC2) degrader based on PROTAC. | |||
T3458 | EED226 | Histone Methyltransferase | |
EED226 is a potent, selective, and orally bioavailable embryonic ectoderm development (EED) inhibitor with an IC50 of 22 nM. | |||
T7378 | BRD9539 | Histone Methyltransferase | |
BRD9539 is an inhibitor of euchromatin histone methyltransferase 2 (EHMT2), also known as G9a, with an IC50 value of 6.3 μM | |||
T1788 | Tazemetostat | E-7438,EPZ6438 | Histone Methyltransferase |
Tazemetostat (EPZ6438) is a histone methyltransferase EZH2 inhibitor (IC50=11 nM) that is orally active, selective, and SAM-competitive. Tazemetostat exhibits antitumor activity and may be used for the treatment of epith... | |||
T17002 | Tazemetostat hydrobromide | E-7438 hydrobromide,EPZ-6438 hydrobromide | Histone Methyltransferase |
Tazemetostat hydrobromide (E-7438 hydrobromide) is a potent and selective EZH2 inhibitor. Tazemetostat hydrobromide inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 (Ki: 2.5 n... | |||
T10205 | A-395 | Histone Methyltransferase | |
A-395 is an antagonist of polycomb repressive complex 2 (PRC2) protein-protein interactions that potently inhibits the trimeric PRC2 complex (EZH2-EED-SUZ12, IC50: 18 nM). | |||
T60044 | SPEN-IN-1 | Others | |
SPEN-IN-1 binding suppresses histone H3K27 trimethylation and blocks initiation of X-chromosome inactivation. SPEN-IN-1 binding reduces the conformational space of RepA and displaces cognate interacting protein factors i... | |||
T29231 | ZLD1039 | ZLD-1039,ZLD 1039 | Histone Methyltransferase |
ZLD1039 is a potent, orally bioavailable EZH2 (Enhancer of Zeste Homolog 2) inhibitor with high selectivity. It demonstrates strong, concentration-dependent inhibition of both wild-type and mutant (Y641F and A677G) PRC2 ... | |||
T61825 | EED ligand 1 | ||
EED ligand 1 is a highly versatile, potent, and effective inhibitor that specifically targets the EED subunit of the polycomb repressive complex 2 (PRC2) methyltransferase. | |||
T12554 | PROTAC EED degrader-2 | Others | |
PROTAC EED degrader-2 is a PROTAC targeting EED (pKD of 9.27),is a inhibitor of polycomb repressive complex 2 (PRC2) with pIC50 of 8.11. | |||
T17931 | EED226-COOH | Others | |
EED226-COOH, derived from EED226, serves as a ligand targeting the EED protein for PROTAC applications. It attaches to a VHL ligand through a linker, culminating in the formation of UNC6852, which specifically degrades P... | |||
T17653 | Boc-NH-C4-acid | Others , PROTAC Linker | |
Boc-NH-C4-acid is a PROTAC linker belonging to the Alkyl/ether class, which can be used for the synthesis of PROTAC1 and can degrade EED, EZH2, and SUZ12 in PRC2. | |||
T12553 | PROTAC EED degrader-1 | Others | |
PROTAC EED degrader-1 is a PROTAC targeting EED (pKD = 9.02), is a inhibitor of polycomb repressive complex 2 (PRC2) with pIC50 of 8.17. | |||
T15240 | Tazemetostat trihydrochloride | EPZ-6438 trihydrochloride,E-7438 trihydrochloride | Histone Methyltransferase |
Tazemetostat trihydrochloride is a selective and orally available inhibitor of EZH2 (IC50: 4 nM for rat EZH2). It inhibits the activity of human PRC2-containing wild-type EZH2 (Ki: 2.5 nM). It inhibits EZH2 (IC50s: 11 an... | |||
T69771 | MS-177 | ||
MS177, a potent and rapid EZH2 degrader, functions as a PROTAC comprised of a CRBN ligand, linker, and a powerful enzymatic EZH2 inhibitor C24 (C24 IC50: 12 nM). It successfully targets and depletes both canonical EZH2–P... | |||
T73134 | EZH2-IN-14 | ||
EZH2-IN-14 is a selective inhibitor of EZH2 (Histone Methyltransferase), demonstrating potent inhibition with an IC50 value of 12 nM. It specifically targets the methyltransferase activity of EZH2/PRC2, effectively reduc... | |||
TN2646 | 16-Hydroxycleroda-3,13-dien-15,16-olide | Autophagy | |
16-Hydroxycleroda-3,13-dien-15,16-olide, and prodigiosin are presented as candidates for autophagy inducers that can trigger cell death in a supplement or alternative medicine for cancer therapy. 16-Hydroxycleroda-3,13-d... |